Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A3CMGM5
Mon, 31.03.2025
APONTIS PHARMA AG
APONTIS PHARMA with significant sales and earnings increase in 2024 financial year – squeeze-out and merger planned
Sales increases significantly to EUR 48.5 million in 2024 financial year (2023: EUR 37.0 million)
Strong increase in Single Pill combination revenues to EUR 34.4 million (2023: EUR 25.6 million)
EBITDA increases by EUR 16.8 mill [ … ]